Agilent Technologies Inc. today announced the launch of a real-time reverse transcription PCR-based diagnostic kit for the detection of SARS-CoV-2 RNA. Agilent’ s kit is intended for the ...

Real-time polymerase chain reaction (PCR) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to grow at a CAGR ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR System.

Applied Biosystems and Agilent reach settlement agreement regarding real-time PCR thermal cyclers. By Reuters. September 18, 2007 8:12 PM UTC Updated September 18, 2007 ...